Skip to content

    GMM Pfaudler

    GMMPFAUDLRMixed
    Capital Goods·6 Feb 2025
    Management Summary

    GMM Pfaudler reported a stable Q3 FY25 revenue of INR 801 crores, with EBITDA up 3% QoQ and margins improving to 12%. Order intake remained strong at INR 798 crore, contributing to a 7% increase in backlog to INR 1740 crore. Management highlighted progress in cost rationalization, manufacturing footprint optimization, and diversification away from cyclical chemical and pharma sectors, targeting a 15% margin profile and reduced segment exposure in the medium term, despite a cautious outlook on market recovery.

    Highlights

    8
    • Revenue for Q3 FY25 was stable at approximately INR 801 crores.

    • EBITDA for Q3 FY25 increased by 3% compared to the previous quarter.

    • EBITDA margins improved slightly to 12% in Q3 FY25, up from 11.6% in the previous quarter.

    • Q3 FY25 order intake was strong at INR 798 crore, representing a 5% increase compared to the previous quarter.

    • On a nine-month basis, order intake grew by 13% compared to the previous nine months.

    • Order backlog stands at INR 1740 crore, a 7% increase compared to December 31st, 2023.

    • The company aims for a 15% margin profile across its businesses in the medium term.

    • Exposure to chemical and pharma segments is targeted to reduce to 50% over the next couple of years.

    What Changed1

    vs Q4 FY25

    Guidance items7 → 5 (-2)
    Key financials

    Metrics

    6

    Periods

    3

    Headline

    4
    • Revenue
      ₹801 Cr
      QoQ0%
    • EBITDA Growth
      3%
      QoQ+3%
    • EBITDA Margin
      12%
      QoQ+3.5%
    • Order Backlog
      ₹1,740 Cr
      YoY+7.0%

    Q3

    1
    • Order Intake
      ₹798 Cr
      QoQ+5%

    9M

    1
    • Order Intake Growth
      13%
      YoY+13%

    Guidance & targets

    5
    CategoryTargetPriority
    Profitability
    EBITDA Margin Profile
    15%
    Medium
    Profitability
    Overall EBITDA Margins
    Improvement
    Medium
    Market Exposure
    Chemical and Pharma Revenue Contribution
    50%
    Medium
    Business Growth
    Heavy Engineering Business Growth
    big growth driver
    Medium
    Strategic Vision
    Articulation of Long-Term Vision
    Articulate vision
    Medium

    Risks & concerns

    4
    RiskSeverity

    Slowdown in Chemical Industry (especially agrochemicals)

    The chemical industry, which forms a major part of our order intake, is a bit slow, mainly driven by the slowdown in agrochemical industries.Management acknowledged

    medium

    Cyclicality of Chemical and Pharmaceutical Industries

    With the cyclicality that comes with these markets, diversification becomes an important part of our strategy.Management acknowledged

    medium

    International Business Slowdown (especially Europe and China)

    International business will see a little bit of slowdown, continuing longer than expected in India, with headwinds especially in China.Management acknowledged

    medium

    Market Recovery Slower Than Expected

    The market didn't turn as early as management would have liked, with a few more quarters expected before a full turnaround in chemical and pharmaceutical industries.Management acknowledged

    medium

    Q&A highlights

    3

    “One is flattening of the decline in glass line so we have sort of stabilized and starting to grow both volumes and pricing in glass line, but also the actions we have taken to improve our cost position in our business.”

    Reveals the underlying drivers of India business improvement, specifically the stabilization and recovery in the core GLE segment, coupled with cost rationalization and diversification efforts.

    asked by Jaiveer Shekhawat

    3 min read6 chapters

    Detailed Narrative

    01

    Q3 FY25 Financial Performance Overview

    GMM Pfaudler reported a stable revenue of approximately INR 801 crores for Q3 FY25. EBITDA saw a 3% increase quarter-on-quarter, with EBITDA margins improving slightly to 12% from 11.6% in the previous quarter. The company's Q3 order intake was strong at INR 798 crore, marking a 5% increase sequentially, and the nine-month order intake was up 13% year-on-year. The order backlog stood at INR 1740 crore, a 7% increase compared to December 31st, 2023.

    02

    Market Outlook and Diversification Strategy

    Management noted a continued slowdown in the chemical industry, particularly agrochemicals, but observed a slightly more positive outlook than six months prior, expecting some investment return in the next couple of quarters. Recognizing the cyclicality of its core chemical and pharma markets, GMM Pfaudler is actively pursuing diversification. The company aims to reduce its revenue exposure to chemical and pharma segments to 50% over the next couple of years, focusing on new industries like oil & gas, petrochemicals, metals & minerals, wastewater, and semiconductors where market share is currently small but growth potential is high.

    03

    Cost Rationalization and Manufacturing Footprint

    The company has diligently worked on its cost structure, including rationalizing its manufacturing footprint. In India, all glass-lined production has been consolidated into the Gujarat facility, improving cost absorption and efficiency. The small Hyderabad factory, previously acquired from De-Dietrich, has ceased production, with operations consolidated in Gujarat to optimize fixed costs, though a sales and service presence is maintained in the South market.

    04

    International Business and Poland Strategy

    The international business experienced a slowdown, particularly in Europe and China, which is expected to continue for a bit longer. To counter this, GMM Pfaudler is rationalizing manufacturing internationally, including moving production from high-cost Western countries to lower-cost European countries like Poland. The company has already executed two successful orders in Poland and plans for a third, with expectations for this strategy to improve efficiencies in Germany and Italy. The UK manufacturing footprint has also been rationalized to improve costs.

    05

    India Business Performance and Services Growth

    The India business has shown an uptick in revenues and margins after several quarters of decline, driven by the stabilization and recovery of glass-lined volumes and pricing, as well as improved cost positions. Non-glass-lined businesses, especially mixing, heavy engineering, and solid-liquid separation, are also contributing significantly to the improved backlog. Services, currently a single-digit percentage of India revenue, are a priority growth area, aiming to replicate the 35%-40% contribution seen in the international business, with initial results showing promise.

    06

    Margin Outlook and Long-Term Vision

    EBITDA margins improved to 12% in Q3 FY25, and management expects further improvement in the next financial year, targeting a 15% margin profile across all businesses in the medium term. While the current year is focused on stability and backlog building, the company is working on articulating a long-term strategic vision to the capital markets in the next financial year. This vision will encompass continued diversification, operational efficiency, and leveraging global manufacturing capabilities to deliver consistent quality and timely delivery regardless of manufacturing location.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.